Clinical trial
Lipoic Acid for the Treatment of Progressive Multiple Sclerosis
NCT03161028 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipoic Acid for the Treatment of Progressive Multiple Sclerosis
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 17, 2018
- Completion date
- June 30, 2024
- Enrollment
- 115 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.